Quinolinium, 1-(2-ethoxy-2-oxoethyl)-6-methoxy-, bromide (1:1), 99%, 250mg

(6-Hydroxynaphthalen-2-yl)boronic acid, 95.0%, 100g

3,5-Di-tert-butyl-4-hydroxybenzoic acid, 97.0%, 500g

N-HYDROXY-4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE, 95.0%, 1g

3-Bromofuran-2,5-dione, 95.0%, 1g

8-Methoxyquinazolin-4-ol, 95.0%, 1g

Sample vials ROTILABO® with short thread ND9, Transparent PP, with graduations, 1.5 ml, 100 Piece(s)

2-METHYLTHIOPYRIDINE, 97.0%, 10g

4-Hydroxybenzonitrile>98.0%(GC)(T)25g

2-Fluoro-3-hydroxybenzonitrile, 95.0%, 25g

3,4,6-Tri-O-acetyl-2-deoxy-D-glucopyranose>98.0%(GC)100mg

2-Bromo-1-(4-cyclohexylphenyl)ethanone, 95%, 2g

(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)acetic acid, 95.0%, 2.5g